Transfection Technologies Market by Method (Instrument-Based Method, Reagent-Based Method), Application (Biomedical Research, Protein Production, Therapeutic Delivery)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,749	181 Pages	360iResearch	January, 2024	IRE18450810

Best Price Guarantee
Price	from $4,749
Length	181 Pages
Publisher	360iResearch
Published Date	January, 2024
SKU	IRE18450810

Transfection Technologies Market by Method (Instrument-Based Method, Reagent-Based Method), Application (Biomedical Research, Protein Production, Therapeutic Delivery) - Global Forecast 2024-2030

The Transfection Technologies Market size was estimated at USD 874.34 million in 2023 and expected to reach USD 945.91 million in 2024, at a CAGR 7.36% to reach USD 1,437.45 million by 2030.

Global Transfection Technologies Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Transfection Technologies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transfection Technologies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Transfection Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Altogen Biosystems, Bio-Rad Laboratories, Inc., Biomol GmbH, Epoch Life Science, F. Hoffmann-La Roche AG, FUJIFILM Wako Pure Chemical Corporation, Geno Technology, Inc., Lonza Group, Maxcyte Inc., Merck KGaA, Mirus Bio, OriGene Technologies, Inc., OZ Biosciences, Polyplus-transfection SA by Sartorius AG, Promega Corporation, Qiagen NV, Reprocell Inc., SignaGen Laboratories, Takara Bio Inc., Thermo Fisher Scientific, Inc., and VWR International, LLC by Avantor.

Market Segmentation & Coverage

This research report categorizes the Transfection Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

Method
Instrument-Based Method
Reagent-Based Method
Application
Biomedical Research
Protein Production
Therapeutic Delivery
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Transfection Technologies Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transfection Technologies Market?
3. What are the technology trends and regulatory frameworks in the Transfection Technologies Market?
4. What is the market share of the leading vendors in the Transfection Technologies Market?
5. Which modes and strategic moves are suitable for entering the Transfection Technologies Market?

Note: PDF & Excel + Online Access - 1 Year

1. Preface: 1.1. Objectives of the Study; 1.2. Market Segmentation & Coverage; 1.3. Years Considered for the Study; 1.4. Currency & Pricing; 1.5. Language; 1.6. Limitations; 1.7. Assumptions; 1.8. Stakeholders
2. Research Methodology: 2.1. Define: Research Objective; 2.2. Determine: Research Design; 2.3. Prepare: Research Instrument; 2.4. Collect: Data Source; 2.5. Analyze: Data Interpretation; 2.6. Formulate: Data Verification; 2.7. Publish: Research Report; 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview: 4.1. Introduction; 4.2. Transfection Technologies Market, by Region
5. Market Insights: 5.1. Market Dynamics; 5.1.1. Drivers; 5.1.1.1. Increasing drug development and vaccine production activities; 5.1.1.2. Rising focus of the biotechnology industry to build single-cell analytic capabilities; 5.1.2. Restraints; 5.1.2.1. Complexity associated with designing and initiating a transfection assay or instrument; 5.1.3. Opportunities; 5.1.3.1. Advancements in transfection technologies with AI and ML; 5.1.3.2. Government initiatives to promote gene therapy and cancer research; 5.1.4. Challenges; 5.1.4.1. Concerns associated with cytotoxicity and inflammatory response; 5.2. Market Segmentation Analysis; 5.3. Market Trend Analysis; 5.4. Cumulative Impact of High Inflation; 5.5. Porter’s Five Forces Analysis; 5.5.1. Threat of New Entrants; 5.5.2. Threat of Substitutes; 5.5.3. Bargaining Power of Customers; 5.5.4. Bargaining Power of Suppliers; 5.5.5. Industry Rivalry; 5.6. Value Chain & Critical Path Analysis; 5.7. Regulatory Framework
6. Transfection Technologies Market, by Method: 6.1. Introduction; 6.2. Instrument-Based Method; 6.3. Reagent-Based Method
7. Transfection Technologies Market, by Application: 7.1. Introduction; 7.2. Biomedical Research; 7.3. Protein Production; 7.4. Therapeutic Delivery
8. Americas Transfection Technologies Market: 8.1. Introduction; 8.2. Argentina; 8.3. Brazil; 8.4. Canada; 8.5. Mexico; 8.6. United States
9. Asia-Pacific Transfection Technologies Market: 9.1. Introduction; 9.2. Australia; 9.3. China; 9.4. India; 9.5. Indonesia; 9.6. Japan; 9.7. Malaysia; 9.8. Philippines; 9.9. Singapore; 9.10. South Korea; 9.11. Taiwan; 9.12. Thailand; 9.13. Vietnam
10. Europe, Middle East & Africa Transfection Technologies Market: 10.1. Introduction; 10.2. Denmark; 10.3. Egypt; 10.4. Finland; 10.5. France; 10.6. Germany; 10.7. Israel; 10.8. Italy; 10.9. Netherlands; 10.10. Nigeria; 10.11. Norway; 10.12. Poland; 10.13. Qatar; 10.14. Russia; 10.15. Saudi Arabia; 10.16. South Africa; 10.17. Spain; 10.18. Sweden; 10.19. Switzerland; 10.20. Turkey; 10.21. United Arab Emirates; 10.22. United Kingdom
11. Competitive Landscape: 11.1. FPNV Positioning Matrix; 11.2. Market Share Analysis, By Key Player; 11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio: 12.1. Key Company Profiles; 12.1.1. Agilent Technologies, Inc.; 12.1.2. Altogen Biosystems; 12.1.3. Bio-Rad Laboratories, Inc.; 12.1.4. Biomol GmbH; 12.1.5. Epoch Life Science; 12.1.6. F. Hoffmann-La Roche AG; 12.1.7. FUJIFILM Wako Pure Chemical Corporation; 12.1.8. Geno Technology, Inc.; 12.1.9. Lonza Group; 12.1.10. Maxcyte Inc.; 12.1.11. Merck KGaA; 12.1.12. Mirus Bio; 12.1.13. OriGene Technologies, Inc.; 12.1.14. OZ Biosciences; 12.1.15. Polyplus-transfection SA by Sartorius AG; 12.1.16. Promega Corporation; 12.1.17. Qiagen NV; 12.1.18. Reprocell Inc.; 12.1.19. SignaGen Laboratories; 12.1.20. Takara Bio Inc.; 12.1.21. Thermo Fisher Scientific, Inc.; 12.1.22. VWR International, LLC by Avantor; 12.2. Key Product Portfolio
13. Appendix: 13.1. Discussion Guide; 13.2. License & Pricing; FIGURE 1. TRANSFECTION TECHNOLOGIES MARKET RESEARCH PROCESS; FIGURE 2. TRANSFECTION TECHNOLOGIES MARKET SIZE, 2023 VS 2030; FIGURE 3. TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION); FIGURE 4. TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2030 (%); FIGURE 5. TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 6. TRANSFECTION TECHNOLOGIES MARKET DYNAMICS; FIGURE 7. TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2023 VS 2030 (%); FIGURE 8. TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 9. TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%); FIGURE 10. TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 11. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%); FIGURE 12. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 13. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%); FIGURE 14. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 15. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%); FIGURE 16. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%); FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 19. TRANSFECTION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023; FIGURE 20. TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023

Transfection Technologies Market – By Product (Kits and Reagents, Equipment), Method (Physical Transfection, Biochemical-based Transfection), Application (Therapeutic Delivery, Biomedical Research), End-use – Global Forecast (2024 – 2032)

April, 2024 | Published by: Global Market Insights | USD $4,850
Transfection Reagents and Equipment Market Report by Product (Reagents, Equipment), Technology (Biochemical Based Transfection, Physical Transfection, Viral-Vector Based Transfection), Application (Biomedical Research, Protein Production, Therapeutic Delivery), End User (Pharmaceutical and Biotechnology Companies, Academics and Research Institutes), and Region 2024-2032

April, 2024 | Published by: IMARC Services Pvt. Ltd. | USD $3,899
Europe Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product (Reagents and Instruments), Method (Viral Methods, Non Viral Methods, and Hybrid Methods), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), and End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies)

July, 2024 | Published by: The Insight Partners | USD $3,550
South & Central America Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product (Reagents and Instruments), Method (Viral Methods, Non Viral Methods, and Hybrid Methods), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), and End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies)

July, 2024 | Published by: The Insight Partners | USD $3,550
Asia Pacific Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product (Reagents and Instruments), Method (Viral Methods, Non Viral Methods, and Hybrid Methods), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), and End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies)

July, 2024 | Published by: The Insight Partners | USD $3,550
Middle East & Africa Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product (Reagents and Instruments), Method (Viral Methods, Non Viral Methods, and Hybrid Methods), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), and End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies)

July, 2024 | Published by: The Insight Partners | USD $3,550

PDF E-mail From Publisher:	$4,749
PDF E-mail From Publisher (2-5)Users License:	$5,749
Site License:	$6,749
Global Site License Fulfilled by Publisher:	$8,749

Transfection Technologies Market by Method (Instrument-Based Method, Reagent-Based Method), Application (Biomedical Research, Protein Production, Therapeutic Delivery) - Global Forecast 2024-2030

Transfection Technologies Market by Method (Instrument-Based Method, Reagent-Based Method), Application (Biomedical Research, Protein Production, Therapeutic Delivery) - Global Forecast 2024-2030

Research Assistance

Other tasks

Transfection Technologies Market by Method (Instrument-Based Method, Reagent-Based Method), Application (Biomedical Research, Protein Production, Therapeutic Delivery) - Global Forecast 2024-2030

Transfection Technologies Market by Method (Instrument-Based Method, Reagent-Based Method), Application (Biomedical Research, Protein Production, Therapeutic Delivery) - Global Forecast 2024-2030

Transfection Technologies Market – By Product (Kits and Reagents, Equipment), Method (Physical Transfection, Biochemical-based Transfection), Application (Therapeutic Delivery, Biomedical Research), End-use – Global Forecast (2024 – 2032)

Research Assistance

Other tasks